ALLMedicine™ Ampullectomy Center
Research & Reviews 67 results
https://doi.org/10.1097/XCS.0000000000000666
Journal of the American College of Surgeons; Swanson J, Littau M et. al.
Feb 28th, 2023 - The efficacy of local excision (transduodenal or endoscopic ampullectomy) in treating early-stage ampullary cancer has not been well defined. We queried the National Cancer Database to identify patients undergoing either local tumor excision or ra...
https://clinicaltrials.gov/ct2/show/NCT05746884
Feb 28th, 2023 - This is a post-marketing follow-up study of a CE marked medical device, controlled, comparative, randomized, multicentre, international single-blind. The main objective is to evaluate the efficacy and safety of PuraStat in duodenal endoscopic muco...
https://doi.org/10.1016/j.surg.2022.12.005
Surgery Miyamoto R, Takahashi A et. al.
Jan 26th, 2023 - Transduodenal ampullectomy has been attempted in ampullary tumors, including early ampullary cancer. However, the indication and extent of transduodenal ampullectomy with curative intent remain controversial. Herein, we address the perioperative a...
https://doi.org/10.1016/j.surg.2022.12.011
Surgery Karam E, Hollenbach M et. al.
Jan 16th, 2023 - Ampullary lesions are rare and can be locally treated either with endoscopic papillectomy or transduodenal surgical ampullectomy. Management of local recurrence after a first-line treatment has been poorly studied. Patients with a local recurrence...
https://doi.org/10.1245/s10434-022-12867-5
Annals of Surgical Oncology; Cai H, Gao P et. al.
Dec 13th, 2022 - The procedure of choice for the resection of ampullary tumors comprises transduodenal ampullectomy (TDA), endoscopic papillectomy (EP), and pancreaticoduodenectomy (PD).1 For neoplasms with low-grade dysplasia, TDA and EP have equivalent efficacie...
Clinicaltrials.gov 3 results
https://clinicaltrials.gov/ct2/show/NCT05746884
Feb 28th, 2023 - This is a post-marketing follow-up study of a CE marked medical device, controlled, comparative, randomized, multicentre, international single-blind. The main objective is to evaluate the efficacy and safety of PuraStat in duodenal endoscopic muco...
https://clinicaltrials.gov/ct2/show/NCT02032784
Jul 16th, 2020 - Inclusion Criteria: Duodenal or ampullary adenoma greater than or equal to 10mm. Duodenal or ampullary adenoma that is suitable for endoscopic mucosal resection. Medically fit for anesthesia, endoscopy, and EMR Able to provide Informed Consent 18 ...
https://clinicaltrials.gov/ct2/show/NCT02825524
Aug 28th, 2017 - Neoplastic lesions may persist at the termination of the common bile duct or pancreatic duct, after endoscopic ampullectomy for adenoma. Such lesions conduct to a difficult therapeutic problem because surgery (pancreaticoduodenectomy or trans-duod...
News 2 results
https://www.mdedge.com/gihepnews/article/255250/gi-oncology/endoscopic-management-duodenal-and-ampullary-adenomas
Grace E. Kim, MD, Uzma D. Siddiqui, MD
Jun 7th, 2022 - Duodenal polyps are a relatively rare entity with a reported incidence of 0. 3%-4.
https://www.mdedge.com/gihepnews/article/249972/society-news/new-update-perforation-management
Dec 15th, 2021 - One of the most devastating complications in any endoscopic procedure is a perforation that may result in a life-threatening situation for the patient and abrupt termination of the intended procedure. The new AGA Clinical Practice Update on Endosc.